Similar articles

• A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation).

  Kim BK, Hong MK, Shin DH, Nam CM, Kim JS, Ko YG, Choi D, Kang TS, Park BE, Kang WC, Lee SH, Yoon JH, Hong BK, Kwon HM, Jang Y; RESET Investigators. Kim BK, et al. J Am Coll Cardiol. 2012 Oct 9;60(15):1340-8. doi: 10.1016/j.jacc.2012.06.043. Epub 2012 Sep 19. J Am Coll Cardiol. 2012. PMID: 22999717 Clinical Trial.
• Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.

  Feres F, Costa RA, Abizaid A, Leon MB, Marin-Neto JA, Botelho RV, King SB 3rd, Negoita M, Liu M, de Paula JE, Mangione JA, Meireles GX, Castello HJ Jr, Nicolela EL Jr, Perin MA, Devito FS, Labrunie A, Salvadori D Jr, Gusmão M, Staico R, Costa JR Jr, de Castro JP, Abizaid AS, Bhatt DL; OPTIMIZE Trial Investigators. Feres F, et al. JAMA. 2013 Dec 18;310(23):2510-22. doi: 10.1001/jama.2013.282183. JAMA. 2013. PMID: 24177257 Clinical Trial.
• Double antiplatelet therapy after drug-eluting stent implantation: risk associated with discontinuation within the first year.

  Ferreira-González I, Marsal JR, Ribera A, Permanyer-Miralda G, García-Del Blanco B, Martí G, Cascant P, Masotti-Centol M, Carrillo X, Mauri J, Batalla N, Larrousse E, Martín E, Serra A, Rumoroso JR, Ruiz-Salmerón R, de la Torre JM, Cequier A, Gómez-Hospital JA, Alfonso F, Martín-Yuste V, Sabatè M, García-Dorado D. Ferreira-González I, et al. J Am Coll Cardiol. 2012 Oct 9;60(15):1333-9. doi: 10.1016/j.jacc.2012.04.057. Epub 2012 Sep 19. J Am Coll Cardiol. 2012. PMID: 22999716
• [Perioperative antiplatelet therapy of patients with coronary stents].

  Chatterjee T, Akin I, Rehders TC, Chatterjee A, Schüpfer C, Nienaber CA, Ince H. Chatterjee T, et al. Praxis (Bern 1994). 2009 Oct 21;98(21):1199-210. doi: 10.1024/1661-8157.98.21.1199. Praxis (Bern 1994). 2009. PMID: 19844878 Review. German.
• Antiplatelet therapy after placement of a drug-eluting stent: a review of efficacy and safety studies.

  Mohammad RA, Goldberg T, Dorsch MP, Cheng JW. Mohammad RA, et al. Clin Ther. 2010 Dec;32(14):2265-81. doi: 10.1016/j.clinthera.2011.01.003. Clin Ther. 2010. PMID: 21353100 Review.